Clinical Trial Update: S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from Yonsei University evaluating S-1, cisplatin, and radiation therapy for operable esophageal cancer (stages IIA, III, or IVA)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Yonsei University | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN